Free Trial

Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form

Salarius Pharmaceuticals logo
$0.95 -0.01 (-1.13%)
Closing price 04:00 PM Eastern
Extended Trading
$0.92 -0.03 (-3.68%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Salarius Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/21/2025
3:30 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
5:56 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
5:00 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
01/21/2025
7:01 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/17/2025
4:17 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:36 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B3
01/13/2025
7:09 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2024
11:15 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form EFFECT
12/27/2024
3:35 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
12/23/2024
11:22 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
5:12 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/01/2024
4:05 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEFA14A
11/01/2024
4:04 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEF 14A
09/27/2024
3:01 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
4:10 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
4:01 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
07/25/2024
4:03 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
4:25 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
07/19/2024
4:13 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
7:15 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:05 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:11 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
04/12/2024
3:50 PM
Arthur David J. (Reporting)
Salarius Pharmaceuticals, Inc. (Issuer)
Salarius Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:03 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEF 14A
03/26/2024
3:05 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:SLRX) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners